SCHEMBL6819086

SCHEMBL6819086

CCCCCCOc1ccccc1-c1cc(C(=O)OCC)no1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 13/20 0.64
FAAH O00519 2/20 0.62
MAPT P10636 4/20 0.49
ALDH1A1 P00352 2/20 0.49
THRB P10828 1/20 0.49
NPC1 O15118 1/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
RAB9A P51151 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP19A1 P11511 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MEN1 O00255 1/20 0.47
NR1I2 O75469 1/20 0.47
LMNA P02545 1/20 0.47
CHRM2 P08172 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADRA2A P08913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6818280 0.99 CNR2 (0.66) CNR2FAAHMAPTALDH1A1THRB
SCHEMBL6818513 0.88 MAPT (0.54) CNR2FAAHMAPTALDH1A1THRB
SCHEMBL6813770 0.88 MAPT (0.57) CNR2FAAHMAPTALDH1A1THRB
SCHEMBL6818115 0.87 CNR2 (0.51) CNR2FAAHMAPTALDH1A1THRB
SCHEMBL6813643 0.87 CNR2 (0.68) CNR2FAAHALDH1A1NPC1HPGD
SCHEMBL6819659 0.86 CNR2 (0.51) CNR2FAAHMAPTALDH1A1THRB
SCHEMBL6818455 0.86 CNR2 (0.69) CNR2FAAHALDH1A1NPC1HPGD
SCHEMBL7072565 0.85 ALDH1A1 (0.53) CNR2FAAHMAPTALDH1A1THRB
SCHEMBL22619918 0.83 RAB9A (0.67) MAPTALDH1A1THRBNPC1HPGD
SCHEMBL6818227 0.83 MAPT (0.50) CNR2FAAHMAPTALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 CNR2 3495/4885FAAH 737/4885MAPT 4759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.